Background The leading cause of death in patients hospitalized for acute my
ocardial infarction is cardiogenic shock. We conducted a randomized trial t
o evaluate early revascularization in patients with cardiogenic shock.
Methods Patients with shock due to left ventricular failure complicating my
ocardial infarction were randomly assigned to emergency revascularization (
152 patients) or initial medical stabilization (150 patients). Revasculariz
ation was accomplished by either coronary-artery bypass grafting or angiopl
asty. Intraaortic balloon counterpulsation was performed in 86 percent of t
he patients in both groups. The primary end point was mortality from all ca
uses at 30 days. Six-month survival was a secondary end point.
Results The mean (+/-SD) age of the patients was 66+/-10 years, 32 percent
were women, and 55 percent had been transferred from other hospitals. The m
edian time to the onset of shock was 5.6 hours after infarction, and most i
nfarcts were anterior in location. Ninety-seven percent of the patients ass
igned to revascularization underwent early coronary angiography, and 87 per
cent underwent revascularization; only 2.7 percent of the patients assigned
to medical therapy crossed over to early revascularization without clinica
l indication. Overall mortality at 30 days did not differ significantly bet
ween the revascularization and medical-therapy groups (46.7 percent and 56.
0 percent, respectively; difference, -9.3 percent; 95 percent confidence in
terval for the difference, -20.5 to 1.9 percent; P = 0.11). Six-month morta
lity was lower in the revascularization group than in the medical-therapy g
roup (50.3 percent vs. 63.1 percent, P=0.027).
Conclusions In patients with cardiogenic shock, emergency revascularization
did not significantly reduce overall mortality at 30 days. However, after
six months there was a significant survival benefit. Early revascularizatio
n should be strongly considered for patients with acute myocardial infarcti
on complicated by cardiogenic shock. (N Engl J Med 1999;341:625-34.) (C) 19
99, Massachusetts Medical Society.